Serenova A/S: Financial statements 2020
CVR: 30532228
Source: annual report 2020, Danish Business Authority
01/01/2020 – 31/12/2020
Serenova A/S (CVR 30532228) has filed annual accounts for 2020. In 2020, the company reported a gross profit of DKK -54,173 and a net result of DKK -83,198,438 compared with DKK -128,464,518 the year before. Equity in the 2020 report amounted to DKK 7,766,655. The solvency ratio was 36.2%. The company had 1 employee in the financial year.
- Gross Profit
- DKK -54,173
- Profit/Loss
- DKK -83,198,438
- Equity
- DKK 7,766,655
- Total Assets
- DKK 21,464,372
- Employees
- 1
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2020 | - | -54 t. | -83.2 mio. | 7.8 mio. | 1 |
| 2019 | - | -36 t. | -128.5 mio. | 91 mio. | - |
| 2018 | - | 13 t. | -54.8 mio. | 219.4 mio. | - |
| 2017 | - | -4.3 mio. | 274.1 mio. | 274.2 mio. | 0 |
| 2016 | - | -9.2 mio. | -104.1 mio. | 50 t. | 7 |
Official annual report
How creditworthy is Serenova A/S?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2020
Serenova A/S has published its annual report for 2019. Gross profit came to DKK -36,431, and the net result was DKK -128,464,518.
About Serenova A/S
Serenova A/S is a Danish company of the type Aktieselskab based in Solrød Strand, founded in 2008. The company is in liquidation. The company is registered under the industry Ikke-finansielle holdingselskaber. The company was previously named SERENDEX PHARMACEUTICALS A/S and SERENDEX A/S. The management consists of Michael Aslo-Petersen. The company is owned by Sorana Holding A/S. The company has 0 employees (2016). In 2025, the company reported a gross profit of DKK -167,993 and a net result of DKK 38,663,045 compared with DKK -24,273,688 the year before. Equity in the 2025 report amounted to DKK 105,405,408.